Identification of persistent trophoblastic diseases based on a human chorionic gonadotropin regression curve by means of a stepwise piecewise linear regression analysis after the evacuation of uneventful moles

Gynecologic Oncology

Volumn 71, Issue 3, 1998, Pages 376-380

  Shigematsu, Toshiyuki ^a   Kamura, Toshiharu ^a   Saito, Toshiaki ^b   Kaku, Tsunehisa ^a   Nakano, Hitoo ^a   Kinugawa, Naoko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GONADOTROPIN BLOOD LEVEL; HUMAN; HYDATIDIFORM MOLE; MAJOR CLINICAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032438384     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5210     Document Type: Article

References (17)

1. 1. Yedema KA, Verheijen RH, Kenemans P, Schijf CP, Borm GF, Segers MF, Thomas CM: Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve. Am J Obstet Gynecol 168:787-792, 1993
2. 2. Berkowitz RS, Goldstein DP, Marean AR, Bernstein M: Oral contraceptives and postmolar trophoblastic disease. Obstet Gynecol 58:474-477, 1981
3. 3. Kohorn EI: Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut. Obstet Gynecol 59:78-84, 1982
4. 4. Franke HR, Risse EKJ, Kenemans P, Houx PCW, Stolk JG, Vooijs GP: Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands. Obstet Gynecol 62:467-473, 1983
5. 5. Rotmensch J, Rosenshein NB, Block BS: Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia. Gynecol Oncol 29:82-86, 1988
6. 6. Schlaerth JB, Morrow CP, Montz FJ, d'Ablating G: Initial management of hydatidiform mole. Am J Obstet Gynecol 158:1299-1306, 1988
7. 7. Berkowitz RS, Ozturk M, Goldstein DP, Bernstein M, Hill L, Wands JR: Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles. Obstet Gynecol 74:212-216, 1989
8. 8. Curry SL, Schlaerth JB, Kohorn EI, Boyce JB, Gore H, Twiggs LB, Blessing JA: Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncologic Group study). Am J Obstet Gynecol 160:805-811, 1989
9. 9. Morrow CP, Nakamura RM, Schlaerth JB, Gaddis O, Eddy GL: The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve. Am J Obstet Gynecol 151:906-914, 1985
10. 10. Morrow CP, Kletzky OA, Disaia PJ, Townsend DE, Mishell DR, Nakamura RM: Clinical and laboratory correlates of molar pregnancy and trophoblastic disease. Am J Obstet Gynecol 128:424-430, 1977
11. 11. Lurain JR, Brewer JI, Torok EE, Halpern B: Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol 145:591-595, 1983
12. 12. Bagshawe KD, Dent J, Webb J: Hydatidiform mole in England and Wales 1973-83. Lancet 20:673-677, 1986
13. 13. Schlaerth JB, Morrow CP, Kletzky OA, Nalick RH, D'Ablaing GA: Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy. Obstet Gynecol 58:478-482, 1981
14. 14. Jones WB, Lewis JL: Treatment of gestational trophoblastic disease. Am J Obstet Gynecol 120:14-20, 1974
15. 15. Curry SL, Hammond CB, Tyrey L, Creasman WT, Parker RT: Hydatidiform mole: diagnosis, management, and long-term follow-up of 347 patients. Obstet Gynecol 45:1-8, 1975
16. 16. Akazawa K, Nakamura T, Palesch, Y: Power of log-rank test and regression model in clinical trials with heterogenous samples. Statist Med 16:583-597, 1997
17. 17. Dixon WJ, Jennrich R: Stepwise Regression 2R. in Dixon WJ, Jennrich R, Brown MB, Engleman L (eds): BMDP Statistical Software Manual. Berkeley, California Univ. Press, 1990, Vol 1, pp 359-394